Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01531361
Title Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

Advanced Solid Tumor


Sorafenib + Vemurafenib

Crizotinib + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST